FDA Class II Recall: Alinity ci-series System Control Module (SCM), REF: 03R70-01,… by Abbott Laboratories

Key facts

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Abbott Laboratories. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Abbott Laboratories should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Abbott Laboratories directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

Abbott Laboratories’s FDA history

Argus HQ has recorded 15 total FDA actions tied to Abbott Laboratories: 0 warning letters, 15 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Is Alinity ci-series System Control Module (SCM), REF: 03R70-01 recalled?

Yes. FDA lists a Class II recall by Abbott Laboratories for Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20, reported 20251224, with status "Ongoing." FDA recall number: Z-0961-2026.

What is the recall class for Abbott Laboratories's recall?

FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Why was Alinity ci-series System Control Module (SCM), REF: 03R70-01 recalled?

FDA's recall record states the reason as: Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.

Related enforcement actions

• Recall: Abbott Laboratories — Class II recall: Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer Model/Catalo… →
• Recall: Abbott Laboratories — Class II recall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08… →
• Recall: Abbott Laboratories — Class II recall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 04… →
• Recall: Abbott Laboratories — Class II recall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08… →
• Recall: Abbott Laboratories — Class II recall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08… →
• Recall: Abbott Laboratories — Class II recall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08… →
• Recall: Abbott Laboratories — Class II recall: Alinity hq Analyzer, REF: 09P68-01 →
• Recall: Abbott Laboratories — Class II recall: ARCHITECT STAT Myoglobin Reagent Kit, LN 2K43-25 and 2K43-20. →